Active — Not RecruitingNot Applicable

Comprehensive Segmental Revision System

Canada, Denmark, United Kingdom105 participantsStarted 2016-04

Plain-language summary

Clinical Data evaluation to document the performance and clinical outcomes of the Comprehensive Segmental Revision System.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Non Inflammatory Degenerative joint disease, including osteoarthritis, and avascular necrosis * Rheumatoid arthritis * Revision where other devices or treatments have failed * Correction of functional deformity * Oncology applications including bone loss due to tumour resection Exclusion Criteria: * Sepsis ( active) * Infection ( active) * Osteomyelitis (active)

What they're measuring

Implant survivorship assessed according to the implant revisions

Timeframe: 10 years

Trial details

NCT IDNCT03270982

SponsorZimmer Biomet

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2035-12

View on ClinicalTrials.gov More Degenerative Disease trials